An AI software platform has tripled the number of stroke patients achieving functional independence, from 16% to 48%, according to a study by the Royal Berkshire Hospital.
Additional data from the largest real-world evaluation of stroke AI imaging showed that Brainomix 360 Stroke was associated with a more than 50% increase in mechanical thrombectomy, a life-changing stroke treatment.
The platform is powered by highly advanced AI algorithms, supporting clinicians by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients in both specialist and general hospitals.
David Hargroves, NHS Clinical Director for Stroke, said: “This AI decision support technology is revolutionising how we help people who have been affected by stroke.
“It is estimated a patient loses around 2m brain cells a minute at the start of a stroke, which is why quick diagnosis and treatment is so critical. AI decision support software provides real-time interpretation of patients’ brain scans – supporting expert doctors and other NHS staff to make faster treatment decisions.”
Dr Michalis Papadakis, CEO and co-founder, said: “Brainomix is helping clinicians every day improve the level of care they can deliver to stroke patients in the UK and worldwide. We are delighted to see a focus on the unique and powerful impact that our technology is having on patient outcomes, validated by an expanding base of published, real-world evidence.”
Brainomix are specialists in AI-powered imaging tools in stroke and lung fibrosis, and regarded as one of the UK’s most successful AI healthcare companies, having developed their technology through commercial scale up to market launch.
The company has also secured several successful partnerships with NHS England and The Health Innovation Network.
This new platform has been deployed widely across the UK and Europe, where – according to a spokesman – it is the established market leader, and in the United States, where it has been validated by a number of world-class stroke institutions and exhibiting a similar clinical impact on stroke care.
